Patent · US Expired

Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity

US6605624B1 · kind B1 · utility

6Cited by

19References

21Claims

0Family size

Assignee

Pharmacia Corporation · SE

Inventors

Len F. Lee · Holden, US
Kevin C. Glenn · Maryland Heights, US
Daniel T. Connolly · Ballwin, US
David Corley · Chesterfield, US
Daniel L. Flynn · Lawrence, US
Ashton T. Hamme · Chesterfield, US
Shridhar Hegde · Beaverton, US
Michele A. Melton · Bridgeton, US
Roger Schilling · Chesterfield, US
James A. Sikorski · Des Peres, US
Nancy N. Wall · Florissant, US
Jeffery A. Zablocki · Skokie, US

Key dates

Filing date	Dec 11, 2000
Grant date	Aug 12, 2003
Priority date	—
Expiry date	Dec 11, 2020

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/44
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A class of substituted pyridines that are useful for inhibiting the activity of cholesteryl ester transfer protein, and have the structural formula (IA), wherein R2, R3, R4, R5, and R6 are defined in the claims.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.